RNXT insider buying

1 cluster buy

RenovoRx, Inc. · Healthcare

When two or more insiders at RenovoRx, Inc. buy RNXT on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in RNXT plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters
1
Distinct insiders
4
Total bought
$222.8K
Market cap
$42.7M

Detected clusters

  • Apr 7, 2025 – Jan 21, 2026
    Detected Jan 21, 2026
    High conviction4 insiders
    Total bought
    $222.8K
    Market cap
    $42.7M

All notable open-market buys in RNXT

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

DateInsiderSharesPriceValueFiling
Jan 21, 2026
Director, Chief Medical Officer
10,000$1.00$10.0KSEC ↗
Dec 31, 2025
Director, Chief Medical Officer
9,795$0.86$8.4KSEC ↗
Dec 30, 2025
Director, Chief Medical Officer
205$0.83$170.2SEC ↗
Dec 18, 2025
Director, Chief Executive Officer
5,000$0.90$4.5KSEC ↗
Dec 17, 2025
Director, Chief Executive Officer
5,000$0.85$4.3KSEC ↗
Dec 16, 2025
Director, Chief Medical Officer
12,000$0.85$10.2KSEC ↗
Dec 5, 2025
Director, Chief Medical Officer
10,000$0.96$9.6KSEC ↗
Nov 24, 2025
Director, Chief Medical Officer
12,000$0.80$9.6KSEC ↗
Nov 21, 2025
Director, Chief Medical Officer
10,000$0.80$8.0KSEC ↗
Aug 25, 2025
Director, Chief Executive Officer
5,000$0.91$4.6KSEC ↗
Aug 22, 2025
Director, Chief Executive Officer
5,000$0.95$4.8KSEC ↗
Jun 5, 2025
Director, Chief Medical Officer
21,000$1.40$29.4KSEC ↗
Apr 15, 2025
Director, Chief Medical Officer
15,000$0.90$13.5KSEC ↗
Apr 15, 2025
Director, Chief Executive Officer
7,500$0.91$6.8KSEC ↗
Apr 11, 2025
Director, Chief Medical Officer
20,000$0.80$16.0KSEC ↗
Apr 10, 2025
Kocak Roncluster
VP Controller and PAO
6,500$0.79$5.1KSEC ↗
Apr 9, 2025
Director, Chief Medical Officer
30,000$0.81$24.3KSEC ↗
Apr 9, 2025
Director, Chief Executive Officer
10,000$0.83$8.3KSEC ↗
Apr 9, 2025
Kocak Roncluster
VP Controller and PAO
6,000$0.80$4.8KSEC ↗
Apr 8, 2025
Director, Chief Medical Officer
26,000$0.84$21.8KSEC ↗
Apr 8, 2025
Director
12,050$0.85$10.2KSEC ↗
Apr 8, 2025
Kocak Roncluster
VP Controller and PAO
95$0.80$76.0SEC ↗
Apr 7, 2025
Director, Chief Executive Officer
10,000$0.83$8.3KSEC ↗

More Healthcare stocks with insider cluster buys

All insider buying in Healthcare

RNXT insider buying — FAQ

Are insiders buying RNXT stock?
Yes — 4 distinct insiders have bought RNXT (RenovoRx, Inc.) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was Jan 22, 2026.
How much RNXT stock have insiders bought?
Insiders have bought a combined $222.8K of RNXT across 23 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in RNXT?
A cluster buy is two or more distinct RenovoRx, Inc. insiders — officers, directors, or 10% owners — each buying RNXT on the open market within a rolling window. RNXT has 1 detected cluster buy to date.
Where does this RNXT insider trading data come from?
Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in RNXT

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy RNXT within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding RNXT.